CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP) Fundamental Analysis & Valuation

NYSE:CIMP • US16934Q8693

Current stock price

25.3 USD
-0.05 (-0.2%)
Last:

This CIMP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CIMP Profitability Analysis

1.1 Basic Checks

  • In the past year CIMP was profitable.
  • CIMP had a negative operating cash flow in the past year.
  • CIMP had positive earnings in 4 of the past 5 years.
  • CIMP had a positive operating cash flow in 4 of the past 5 years.
CIMP Yearly Net Income VS EBIT VS OCF VS FCFCIMP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M

1.2 Ratios

  • CIMP has a better Return On Assets (0.91%) than 61.76% of its industry peers.
  • CIMP has a Return On Equity (5.62%) which is in line with its industry peers.
  • CIMP has a Return On Invested Capital (0.68%) which is in line with its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CIMP is in line with the industry average of 1.29%.
Industry RankSector Rank
ROA 0.91%
ROE 5.62%
ROIC 0.68%
ROA(3y)0.67%
ROA(5y)0.3%
ROE(3y)3.75%
ROE(5y)1.04%
ROIC(3y)0.82%
ROIC(5y)1.32%
CIMP Yearly ROA, ROE, ROICCIMP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1.3 Margins

  • CIMP has a Profit Margin of 18.10%. This is in the better half of the industry: CIMP outperforms 69.12% of its industry peers.
  • In the last couple of years the Profit Margin of CIMP has grown nicely.
  • CIMP's Operating Margin of 15.62% is in line compared to the rest of the industry. CIMP outperforms 55.88% of its industry peers.
  • CIMP's Operating Margin has declined in the last couple of years.
  • CIMP has a Gross Margin of 31.43%. This is in the lower half of the industry: CIMP underperforms 61.76% of its industry peers.
  • In the last couple of years the Gross Margin of CIMP has declined.
Industry RankSector Rank
OM 15.62%
PM (TTM) 18.1%
GM 31.43%
OM growth 3Y-22.61%
OM growth 5Y-19.82%
PM growth 3YN/A
PM growth 5Y70.35%
GM growth 3Y-12.54%
GM growth 5Y-10.18%
CIMP Yearly Profit, Operating, Gross MarginsCIMP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CIMP Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CIMP is destroying value.
  • Compared to 1 year ago, CIMP has more shares outstanding
  • Compared to 5 years ago, CIMP has more shares outstanding
  • Compared to 1 year ago, CIMP has a worse debt to assets ratio.
CIMP Yearly Shares OutstandingCIMP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
CIMP Yearly Total Debt VS Total AssetsCIMP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • Based on the Altman-Z score of -0.54, we must say that CIMP is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -0.54, CIMP perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
  • CIMP has a Debt/Equity ratio of 4.62. This is a high value indicating a heavy dependency on external financing.
  • With a decent Debt to Equity ratio value of 4.62, CIMP is doing good in the industry, outperforming 60.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 4.62
Debt/FCF N/A
Altman-Z -0.54
ROIC/WACC0.13
WACC5.11%
CIMP Yearly LT Debt VS Equity VS FCFCIMP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 0.05 indicates that CIMP may have some problems paying its short term obligations.
  • With a Current ratio value of 0.05, CIMP is not doing good in the industry: 73.53% of the companies in the same industry are doing better.
  • CIMP has a Quick Ratio of 0.05. This is a bad value and indicates that CIMP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.05, CIMP is not doing good in the industry: 73.53% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
CIMP Yearly Current Assets VS Current LiabilitesCIMP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CIMP Growth Analysis

3.1 Past

  • CIMP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.44%, which is quite good.
  • The earnings per share for CIMP have been decreasing by -17.80% on average. This is quite bad
  • The Revenue has been growing slightly by 5.61% in the past year.
  • CIMP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.79% yearly.
EPS 1Y (TTM)16.44%
EPS 3Y-19.34%
EPS 5Y-17.8%
EPS Q2Q%43.24%
Revenue 1Y (TTM)5.61%
Revenue growth 3Y4.64%
Revenue growth 5Y-7.79%
Sales Q2Q%-65.33%

3.2 Future

  • Based on estimates for the next years, CIMP will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.24% on average per year.
  • CIMP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.24% yearly.
EPS Next Y26.35%
EPS Next 2Y15.88%
EPS Next 3Y12.24%
EPS Next 5YN/A
Revenue Next Year22.17%
Revenue Next 2Y11.89%
Revenue Next 3Y10.24%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CIMP Yearly Revenue VS EstimatesCIMP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
CIMP Yearly EPS VS EstimatesCIMP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. CIMP Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.88, CIMP is valued correctly.
  • CIMP's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.71. CIMP is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 11.78 indicates a reasonable valuation of CIMP.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CIMP is on the same level as its industry peers.
  • CIMP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.09.
Industry RankSector Rank
PE 14.88
Fwd PE 11.78
CIMP Price Earnings VS Forward Price EarningsCIMP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 73.53% of the companies in the same industry are more expensive than CIMP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 67.32
CIMP Per share dataCIMP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • CIMP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CIMP's earnings are expected to grow with 12.24% in the coming years.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y15.88%
EPS Next 3Y12.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CIMP Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 13.47%, CIMP is a good candidate for dividend investing.
  • CIMP's Dividend Yield is a higher than the industry average which is at 12.70.
  • CIMP's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 13.47%

5.2 History

  • The dividend of CIMP decreases each year by -14.90%.
  • CIMP does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)-14.9%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 144.48% of the earnings are spent on dividend by CIMP. This is not a sustainable payout ratio.
DP144.48%
EPS Next 2Y15.88%
EPS Next 3Y12.24%
CIMP Yearly Income VS Free CF VS DividendCIMP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M
CIMP Dividend Payout.CIMP Dividend Payout, showing the Payout Ratio.CIMP Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CIMP Fundamentals: All Metrics, Ratios and Statistics

CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30

NYSE:CIMP (4/21/2026, 8:04:00 PM)

25.3

-0.05 (-0.2%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)02-11
Earnings (Next)05-06
Inst Owners58.25%
Inst Owner ChangeN/A
Ins Owners1.84%
Ins Owner ChangeN/A
Market Cap2.11B
Revenue(TTM)798.15M
Net Income(TTM)144.47M
Analysts71.11
Price Target28.07 (10.95%)
Short Float %0%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield 13.47%
Yearly Dividend2.54
Dividend Growth(5Y)-14.9%
DP144.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.51%
Min EPS beat(2)-20.93%
Max EPS beat(2)3.91%
EPS beat(4)1
Avg EPS beat(4)-11.97%
Min EPS beat(4)-20.93%
Max EPS beat(4)3.91%
EPS beat(8)1
Avg EPS beat(8)-16.68%
EPS beat(12)1
Avg EPS beat(12)-19.66%
EPS beat(16)2
Avg EPS beat(16)-18.35%
Revenue beat(2)0
Avg Revenue beat(2)-27.4%
Min Revenue beat(2)-30.7%
Max Revenue beat(2)-24.11%
Revenue beat(4)0
Avg Revenue beat(4)-21.02%
Min Revenue beat(4)-30.7%
Max Revenue beat(4)-9.79%
Revenue beat(8)4
Avg Revenue beat(8)67.56%
Revenue beat(12)8
Avg Revenue beat(12)86.97%
Revenue beat(16)12
Avg Revenue beat(16)75.93%
PT rev (1m)-2.51%
PT rev (3m)-0.58%
EPS NQ rev (1m)0.64%
EPS NQ rev (3m)4%
EPS NY rev (1m)5.54%
EPS NY rev (3m)1.11%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.75%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.36%
Valuation
Industry RankSector Rank
PE 14.88
Fwd PE 11.78
P/S 2.64
P/FCF N/A
P/OCF N/A
P/B 0.82
P/tB 0.82
EV/EBITDA 67.32
EPS(TTM)1.7
EY6.72%
EPS(NY)2.15
Fwd EY8.49%
FCF(TTM)-3.44
FCFYN/A
OCF(TTM)-2.98
OCFYN/A
SpS9.57
BVpS30.85
TBVpS30.85
PEG (NY)0.56
PEG (5Y)N/A
Graham Number34.35 (35.77%)
Profitability
Industry RankSector Rank
ROA 0.91%
ROE 5.62%
ROCE 1.48%
ROIC 0.68%
ROICexc 0.69%
ROICexgc 0.71%
OM 15.62%
PM (TTM) 18.1%
GM 31.43%
FCFM N/A
ROA(3y)0.67%
ROA(5y)0.3%
ROE(3y)3.75%
ROE(5y)1.04%
ROIC(3y)0.82%
ROIC(5y)1.32%
ROICexc(3y)0.83%
ROICexc(5y)1.35%
ROICexgc(3y)0.84%
ROICexgc(5y)1.36%
ROCE(3y)1.46%
ROCE(5y)2.25%
ROICexgc growth 3Y-20.82%
ROICexgc growth 5Y-22.94%
ROICexc growth 3Y-21.28%
ROICexc growth 5Y-23.3%
OM growth 3Y-22.61%
OM growth 5Y-19.82%
PM growth 3YN/A
PM growth 5Y70.35%
GM growth 3Y-12.54%
GM growth 5Y-10.18%
F-Score5
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 4.62
Debt/FCF N/A
Debt/EBITDA 90.08
Cap/Depr 532.1%
Cap/Sales 4.79%
Interest Coverage 0.23
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -0.54
F-Score5
WACC5.11%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.44%
EPS 3Y-19.34%
EPS 5Y-17.8%
EPS Q2Q%43.24%
EPS Next Y26.35%
EPS Next 2Y15.88%
EPS Next 3Y12.24%
EPS Next 5YN/A
Revenue 1Y (TTM)5.61%
Revenue growth 3Y4.64%
Revenue growth 5Y-7.79%
Sales Q2Q%-65.33%
Revenue Next Year22.17%
Revenue Next 2Y11.89%
Revenue Next 3Y10.24%
Revenue Next 5YN/A
EBIT growth 1Y-17.21%
EBIT growth 3Y-19.02%
EBIT growth 5Y-26.07%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-239.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-221.01%
OCF growth 3YN/A
OCF growth 5YN/A

CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 / CIMP Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30?

ChartMill assigns a fundamental rating of 3 / 10 to CIMP.


Can you provide the valuation status for CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30?

ChartMill assigns a valuation rating of 5 / 10 to CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP). This can be considered as Fairly Valued.


How profitable is CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP) stock?

CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP) has a profitability rating of 4 / 10.


What is the financial health of CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP) stock?

The financial health rating of CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP) is 1 / 10.


Can you provide the dividend sustainability for CIMP stock?

The dividend rating of CHIMERA INVESTMENT CORP - CIM 8 7/8 08/15/30 (CIMP) is 3 / 10 and the dividend payout ratio is 144.48%.